I'm getting a sense that the potential interest in us by outside parties, with their own focused interest in lenz, may becoming realized. This pertains to the party exploring lenz for GvHD, as well as to the party who has been waiting to see an uptick in ICU utilization for covid and other respiratory infections. My basis for this suspected increased interest is the work TeraImmune has been doing, as well as the increased ICU utilization for respiratory indications in Japan, which I find particularly interesting because it targets children and young people, and I don't think the current XBB.1.5 vaccine is compounded to address this patient population.